Lipids and cardiovascular/metabolic health

Risk factors for subclinical renal damage and its progression: Hanzhong Adolescent Hypertension Study

Abstract

Background/Objectives

Chronic kidney disease (CKD) is a global public health problem, including in China. The aim of this study was to identify the risk factors for the development and progression of subclinical renal disease (SRD) in a Chinese population. We also examined whether the impact of the risk factors on SRD changed over time.

Subjects/Methods

To identify the predictors of SRD, we performed a cross-sectional study of the 2432 subjects in our Hanzhong Adolescent Hypertension Cohort. A subgroup of 202 subjects was further analyzed over a 12-year period from 2005 to 2017 to determine the risk factors for the development and progression of SRD.

Results

In cross-sectional analysis, elevated blood pressure, male gender, diabetes, body mass index, and triglyceride were independently associated with a higher risk of SRD. In longitudinal analysis, an increase in total cholesterol over a 4-year period and an increase in serum triglyceride over a 12-year period were independently associated with progression of albuminuria. Finally, increases in both total cholesterol and serum uric acid over a 4-year follow-up showed an independent association with a modest reduction in estimated glomerular filtration rate (eGFR).

Conclusions

In this study of a Chinese cohort, we show several metabolic abnormalities as independent risk factors for subclinical renal disease in a Chinese cohort. In addition, we demonstrate that the effects of total cholesterol, triglycerides and uric acid on the development and progression of albuminuria or the decline in eGFR vary at different points of follow-up. These findings highlight the importance of early detection of metabolic abnormalities to prevent SRD.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Flow diagram showing the recruitment of participants in cross-sectional study.

References

  1. 1.

    Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–22.

    PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–15.

    PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl. 2005;98:S7–10.

    Article  Google Scholar 

  5. 5.

    Wang Y, Chen C, Yan Y, Yuan Y, Wang KK, Chu C, et al. Association of uric acid in serum and urine with subclinical renal damage: Hanzhong Adolescent Hypertension Study. PLoS ONE. 2019;14(11):e0224680.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  6. 6.

    Mule G, Calcaterra I, Costanzo M, Geraci G, Guarino L, Foraci AC, et al. Relationship between short-term blood pressure variability and subclinical renal damage in essential hypertensive patients. J Clin Hypertens. 2015;17:473–80.

    Article  Google Scholar 

  7. 7.

    Zheng W, Mu J, Chu C, Hu J, Yan Y, Ma Q, et al. Association of blood pressure trajectories in early life with subclinical renal damage in middle age. J Am Soc Nephrol. 2018;29:2835–46.

    PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.

  9. 9.

    Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population:a 10-year follow-up study. Kidney Int. 2007;71:159–66.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16:791–9.

    PubMed  Article  PubMed Central  Google Scholar 

  11. 11.

    Chang YH, Lei CC, Lin KC, Chang DM, Hsieh CH, Lee YJ. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study. Diabetes Metab Res Rev. 2016;32:557–64.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93–104.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  13. 13.

    van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79:1341–52.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  14. 14.

    Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–81.

    PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Dabla PK. Renal function in diabetic nephropathy. World J Diabetes. 2010;1:48.

    PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    Mu J, Zheng S, Lian Q, Liu F, Liu Z. Evolution of blood pressure from adolescents to youth in salt sensitivies: a 18-year follow-up study in Hanzhong children cohort. Nutr J. 2012;11:70.

    PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Wang Y, Hu JW, Qu PF, Wang KK, Yan Y, Chu C, et al. Association between urinary sodium excretion and uric acid, and its interaction on the risk of prehypertension among Chinese young adults. Sci Rep. 2018;8:7749.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Wang K, Wang Y, Chu C, Hu J, Zheng W, Yan Y, et al. Joint association of serum homocysteine and high-sensitivity c-reactive protein with arterial stiffness in chinese population: a 12-year longitudinal study. Cardiology. 2019;144:27–35.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Wang Y, Yuan Y, Gao WH, Yan Y, Wang KK, Qu PF, et al. Predictors for progressions of brachial-ankle pulse wave velocity and carotid intima-media thickness over a 12-year follow-up: Hanzhong Adolescent Hypertension Study. J Hypertens. 2019;37:1167–75.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Wang Y, Wang D, Chu C, Mu JJ, Wang M, Liu FQ, et al. Effect of salt intake and potassium supplementation on urinary renalase and serum dopamine levels in Chinese adults. Cardiology. 2015;130:242–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Wang Y, Lv YB, Chu C, Wang M, Xie BQ, Wang L, et al. Plasma renalase is not associated with blood pressure and brachial-ankle pulse wave velocity in chinese adults with normal renal function. Kidney Blood Press Res. 2016;41:837–47.

    PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Wang Y, Liu FQ, Wang D, Mu JJ, Ren KY, Guo TS, et al. Effect of salt intake and potassium supplementation on serum renalase levels in Chinese adults: a randomized trial. Medicine. 2014;93:e44.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Wang Y, Chu C, Wang KK, Hu JW, Yan Y, Lv YB, et al. Effect of salt intake on plasma and urinary uric acid levels in Chinese adults: an interventional trial. Sci Rep. 2018;8:1434.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  24. 24.

    Wang Y, Mu JJ, Geng LK, Wang D, Ren KY, Guo TS, et al. Effect of salt intake and potassium supplementation on brachial-ankle pulse wave velocity in Chinese subjects: an interventional study. Braz J Med Biol Res. 2015;48:83–90.

    PubMed  Article  PubMed Central  Google Scholar 

  25. 25.

    Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–44.

    PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Duan J, Wang C, AUID- Oho, Liu D, Qiao Y, Pan S, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents:a cross-sectional survey. Sci Rep. 2019;9:10408.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  27. 27.

    Zhang L, Wang Z, Chen Y, Wang X, Chen Z, Feng B, et al. Prevalence and risk factors associated with chronic kidney disease in adults living in 3 different altitude regions in the Tibetan Plateau. Clin Chim Acta. 2018;481:212–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  28. 28.

    Kim DM, Ahn CW, Park JS, Cha BS, Lim SK, Kim KR, et al. An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea. Diabetes Res Clin Pract. 2004;66:S169–172.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Tseng CH. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan. Clin Biochem. 2009;42:1019–24.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  30. 30.

    Bjornstad P, Maahs DM, Wadwa RP, Pyle L, Rewers M, Eckel RH, et al. Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study. J Clin Lipido. 2014;8:576–83.

    Article  Google Scholar 

  31. 31.

    Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N. Engl J Med. 2003;348:2285–93.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 2002;62:1743–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. Kidney Int. 2002;61:209–18.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Prinsen BH, de Sain-van der Velden MG, de Koning EJ, Koomans HA, Berger R, Rabelink TJ. Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. Kidney Int Suppl. 2003;84:S121–4.

    CAS  Article  Google Scholar 

  35. 35.

    Hattori M, Nikolic-Paterson DJ, Miyazaki K, Isbel NM, Lan HY, Atkins RC, et al. Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury. Kidney Int Suppl. 1999;71:S47–50.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Chait A, Heinecke JW. Lipoprotein modification: cellular mechanisms. Curr Opin Lipido. 1994;5:365–70.

    CAS  Article  Google Scholar 

  37. 37.

    Reiss AB, Voloshyna I, De Leon J, Miyawaki N, Mattana J. Cholesterol metabolism in CKD. Am J Kidney Dis. 2015;66:1071–82.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  38. 38.

    Wang J, Yu Y, Li X, Li D, Xu C, Yuan J, et al. Serum uric acid levels and decreased estimated glomerular filtration rate in patients with type 2 diabetes: a cohort study and meta-analysis. Diabetes Metab Res Rev. 2018;34:e3046.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  39. 39.

    De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, et al. Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10:1921–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  40. 40.

    Xu Y, Liu X, Sun X, Wang Y. The impact of serum uric acid on the natural history of glomerular filtration rate: a retrospective study in the general population. Peer J. 2016;4:e1859.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  41. 41.

    Takagi M, Babazono T, Uchigata Y. Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease. Diabet Med. 2015;32:1354–60.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    Gu L, Huang L, Wu H, Lou Q, Bian R. Serum uric acid to creatinine ratio: a predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function. Diab Vasc Dis Res. 2017;14:221–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would particularly like to thank Dr Robert Safirstein (Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA) for language editing. Many thanks to Drs. Rui-Hai Yang and Jun Yang (Institute of Cardiovascular Sciences, Hanzhong People’s Hospital, Hanzhong, China) for providing assistance during follow-up. This work was supported by the National Natural Science Foundation of China No. 81600327 (YW), No. 81870319 (J-JM) and No. 81700368 (CC), Institutional Foundation of the First Affiliated Hospital of Xi’an Jiaotong University No. 2019QN-06, the Clinical Research Award of the First Affiliated Hospital of Xi’an Jiaotong University of China No. XJTU1AF-CRF-2017-021 (YW) and XJTU1AF-CRF-2019-004 (J-JM), Grants from China Postdoctoral Science Foundation funded project (Nos. 2018T111075 and 2018M631177), Special Financial Grant from Shaanxi Postdoctoral Science Foundation (2018BSHTDZZ14), Fundamental Research Funds for the Central Universities (No. xjj2018103), Grants from the Major Chronic Non-communicable Disease Prevention and Control Research Key Project of the Ministry of Science and Technology of China (2017YFC1307604 and 2016YFC1300104), and Grant from Key Laboratory of Molecular Cardiology of First Affiliated Hospital of Xi’an Jiaotong University (KLMC-2018-06).

Author information

Affiliations

Authors

Contributions

YW and J-JM conceived and designed the experiments; J-JM and Z-YY was responsible for subject recruitment; YW, M-FD, W-HG, B-WF, QM, YY, YY, CC, CC, Y-YL, KG, K-KW, ML, YS, J-WH, QM, DW, H-WZ and performed the experiments; YW, B-WF, XC, X-YZ and C-HL analyzed the data; YW and M-FD drafted manuscript; W-HL, JC and J-JM edited and revised manuscript. All authors read, critically revised and approved the final manuscript.

Corresponding authors

Correspondence to John Chang or Jian-Jun Mu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Du, MF., Gao, WH. et al. Risk factors for subclinical renal damage and its progression: Hanzhong Adolescent Hypertension Study. Eur J Clin Nutr (2020). https://doi.org/10.1038/s41430-020-00752-x

Download citation

Search

Quick links